Hot Life Science Investor Mandate 10: Social Impact Fund Looking to Eradicate Global Diseases

4 Jun

A social impact investment fund with offices in Europe and the United States fund was launched with a total of $108 million in capital to invest into companies that are improving the quality of lives in low-income countries through the eradication of preventable diseases. The firm looks to allocate anywhere from $3+ million into companies with the ability to allocate up to $15 million over the lifetime of the investment. The firm primarily looks to provide mezzanine debt financing although they can be very flexible in terms of capital structure. The firm is actively reviewing opportunities and is open to invest in companies from around the globe.

The firm is currently looking for companies developing therapeutics, diagnostics, and medical devices. The firm is looking for companies targeting the full spectrum of global diseases including cholera, diarrhea, HIV, malaria, and TB, as well as products for improving global nutrition, maternal health and family planning. The firm is looking for companies that have POC data in humans and require financing to complete their trials, gain country regulatory approval and begin commercialization.

The firm is looking for private or public companies with an experienced management team. The firm looks to take a board/observer seat on a case by case basis in companies where they can add strategic value.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: